Physician profile
Sandra L Hall
NPI 1275643686
$21,283.94
in general payments reported to CMS, 2019-2025
18 companies · $50.87 in 2025
The $50.87 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,805 · 2020: $3,677 · 2021: $38.74 · 2022: $39.86 · 2023: $76.67 · 2024: $7,595 · 2025: $50.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,076 · Travel and Lodging: $992 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,076.00 |
| Travel and Lodging | $991.62 |
| Food and Beverage | $655.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10,222.75 | 2019-2022 | |
| Sanofi Pasteur INC. | $7,500.62 | 2024 | |
| Intuitive Surgical, INC. | $3,000.00 | 2019 | |
| Organon LLC | $116.69 | 2023-2025 | Nexplanon |
| Pfizer INC. | $92.88 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $78.75 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.82 | 2019-2021 | |
| Lupin INC. | $44.99 | 2019 | |
| Hologic Sales and Service, LLC | $37.14 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Smith+Nephew, INC. | $28.58 | 2025 | Stravix |
| Coopersurgical, INC. | $23.18 | 2019 | |
| Astellas Pharma US INC | $20.73 | 2024 | Veozah |
| Duchesnay USA Incorporated | $16.80 | 2019 | |
| Daiichi Sankyo INC. | $16.45 | 2019 | |
| Sanara Medtech INC. | $14.80 | 2024 | Celleraterx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.76 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.